Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,980,000
Closed -$389M 936
2024
Q3
$389M Buy
+1,980,000
New +$370M 0.38% 71
2024
Q2
Sell
-2,656,500
Closed -$483M 1024
2024
Q1
$483M Hold
2,656,500
0.52% 48
2023
Q4
$409M Hold
2,656,500
0.51% 52
2023
Q3
$397M Hold
2,656,500
0.56% 45
2023
Q2
$358M Hold
2,656,500
0.54% 48
2023
Q1
$421M Buy
+2,656,500
New +$406M 0.69% 39
2018
Q4
Sell
-16,000
Closed -$1.51M 747
2018
Q3
$1.51M Buy
+16,000
New +$1.52M 0.01% 479

Other funds holding ABBV

DZ Bank's ABBV Position: Q2 2026 in Review

DZ Bank increased its AbbVie (ABBV) stake by 164% in Q2 2026, buying an estimated $386M and bringing the position to 2,885,557 shares worth $726M. The position accounts for 0.56% of the portfolio, ranked #49.

DZ Bank first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.04B in Q4 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • DZ Bank held 2,885,557 shares of AbbVie worth $726M as of Q2 2026.
  • DZ Bank bought 1,794,272 AbbVie shares in Q2 2026, an estimated $386M.
  • AbbVie made up 0.56% of DZ Bank's portfolio in Q2 2026, its #49 holding.
  • DZ Bank first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
  • DZ Bank's AbbVie position peaked at $2.04B in Q4 2025.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.